{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:46:17Z","timestamp":1791639977661,"version":"4.3.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1038-7","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T15:37:54Z","timestamp":1537457874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease"],"prefix":"10.1186","volume":"19","author":[{"given":"M.","family":"Heitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. L.","family":"Carron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Clavarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Guebre-Egziabher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"key":"1038_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrneph.2011.89","volume":"7","author":"Z Cui","year":"2011","unstructured":"Cui Z, Zhao MH. Advances in human antiglomerular basement membrane disease. Nat Rev Nephrol. 2011;7:697\u2013705.","journal-title":"Nat Rev Nephrol"},{"key":"1038_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1309\/NPTP4UKV7JU3ELMQ","volume":"125","author":"EG Fischer","year":"2006","unstructured":"Fischer EG, Lager DG. Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases. Am J Clin Pathol. 2006;125:445\u201350.","journal-title":"Am J Clin Pathol"},{"key":"1038_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","volume":"134","author":"J-B Levy","year":"2001","unstructured":"Levy J-B, Turner A-N, Rees A-J, Pusey C-D. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033\u201342.","journal-title":"Ann Intern Med"},{"key":"1038_CR4","first-page":"372","volume":"9","author":"F Merkel","year":"1994","unstructured":"Merkel F, Pullig O, Marx M, Netzer KO, Weber M. Course and prognosis of anti-basement membrane antibody (anti-BM-ab)-mediated disease: report of 35 cases. Nephrol Dial Transplant. 1994;9:372\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"1038_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/ki.2012.280","volume":"82","author":"Jai Radhakrishnan","year":"2012","unstructured":"Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines-application to the individual patient. Kidney Int 2012;82(8):840\u2013856. doi: \n                    https:\/\/doi.org\/10.1038\/ki.2012.280\n                    \n                  . Epub 2012 Aug 15.","journal-title":"Kidney International"},{"key":"1038_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00005792-198507000-00003","volume":"64","author":"J-P Johnson","year":"1985","unstructured":"Johnson J-P, Moore J, Austin H-A, Balow J-E, Antonovych T-T, Wilson C-B. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine. 1985;64:219\u201327.","journal-title":"Medicine"},{"key":"1038_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"J-H Stone","year":"2010","unstructured":"Stone J-H, Merkel P-A, Spiera R, Seo P, Langford C-A, Hoffman G-S, et al. RAVE-ITN research group: rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221\u201332.","journal-title":"N Engl J Med"},{"key":"1038_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"R-B Jones","year":"2010","unstructured":"Jones R-B, Tervaert J-W-C, Hauser T, Luqmani R, Morgan M-D, Peh C-A, et al. European Vasculitis study group: rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010;363:211\u201320.","journal-title":"N Engl J Med"},{"key":"1038_CR9","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/ard.61.10.922","volume":"61","author":"K Arzoo","year":"2002","unstructured":"Arzoo K, Sadeghi S, Liebman H-A. Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab). Ann Rheum Dis. 2002;61:922\u20134.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2015.04.003","volume":"60","author":"M Touzot","year":"2015","unstructured":"Touzot M, Poisson J, Faguer S, Ribes D, Cohen P, Geffray L, et al. Rituximab in anti-GBM disease: a retrospective study of 8 patients. J Autoimmun. 2015;60:74\u20139.","journal-title":"J Autoimmun"},{"key":"1038_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.semarthrit.2012.10.007","volume":"42","author":"U-A Syeda","year":"2013","unstructured":"Syeda U-A, Singer NG, Magrey M. Anti-glomerular basement membrane antibody disease treated with rituximab: a case-based review. Semin Arthritis Rheum. 2013;42:567\u201372.","journal-title":"Semin Arthritis Rheum"},{"key":"1038_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1399-0012.2008.00912.x","volume":"23","author":"M Sauter","year":"2009","unstructured":"Sauter M, Schmid H, Anders H-J, Heller F, Weiss M, Sitter T. Loss of a renal graft due to recurrence of anti-GBM disease despite rituximab therapy. Clin Transpl. 2009;23:132\u20136.","journal-title":"Clin Transpl"},{"key":"1038_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/ncpneph0724","volume":"4","author":"E Wechsler","year":"2008","unstructured":"Wechsler E, Yang T, Jordan S-C, Vo A, Nast C-C. Anti-glomerular basement membrane disease in an HIV-infected patient. Nat Clin Pract Nephrol. 2008;4:167\u201371.","journal-title":"Nat Clin Pract Nephrol"},{"key":"1038_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/qjmed\/hcr001","volume":"105","author":"Y Shah","year":"2012","unstructured":"Shah Y, Mohiuddin A, Sluman C, Daryanani I, Ledson T, Banerjee A, et al. Rituximab in anti-glomerular basement membrane disease. QJM. 2012;105:195\u20137.","journal-title":"QJM"},{"issue":"nov24 1","key":"1038_CR15","doi-asserted-by":"publisher","first-page":"bcr2014206220","DOI":"10.1136\/bcr-2014-206220","volume":"2014","author":"M. Narayanan","year":"2014","unstructured":"Narayanan M, Casimiro I, Pichler R. A unique way to treat Goodpasture\u2019s disease. BMJ Case Reports 2014; \n                    https:\/\/doi.org\/10.1136\/bcr-2014-206220\n                    \n                  .","journal-title":"Case Reports"},{"key":"1038_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/ckj\/sft152","volume":"7","author":"G Bandak","year":"2014","unstructured":"Bandak G, Jones B-A, Li J, Yee J, Umanath K. Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy. Clin Kidney J. 2014;7:53\u20136.","journal-title":"Clin Kidney J"},{"key":"1038_CR17","doi-asserted-by":"publisher","first-page":"e103568","DOI":"10.1371\/journal.pone.0103568","volume":"9","author":"P Biesenbach","year":"2014","unstructured":"Biesenbach P, Kain R, Derfler K, Perkmann T, Soleiman A, Benharkou A, et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with Immunoadsorption. PLoS One. 2014;9:e103568.","journal-title":"PLoS One"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1038-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1038-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1038-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T23:05:09Z","timestamp":1568934309000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1038-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1038"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1038-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,20]]},"assertion":[{"value":"23 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our local ethics committee (CPP Grenoble) ruled that no formal ethics approval is required in this particular case, i.e. routine patients \u2018care.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have obtained consent to publish from the patients included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"241"}}